RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497
- PMID: 39335086
- PMCID: PMC11428622
- DOI: 10.3390/antibiotics13090814
RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497
Abstract
The journal retracts the article, "Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa", cited above [...].
Retraction of
-
Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa.Antibiotics (Basel). 2023 Mar 2;12(3):497. doi: 10.3390/antibiotics12030497. Antibiotics (Basel). 2023. Retraction in: Antibiotics (Basel). 2024 Aug 28;13(9):814. doi: 10.3390/antibiotics13090814. PMID: 36978364 Free PMC article. Retracted.
Similar articles
-
Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa.Antibiotics (Basel). 2023 Mar 2;12(3):497. doi: 10.3390/antibiotics12030497. Antibiotics (Basel). 2023. Retraction in: Antibiotics (Basel). 2024 Aug 28;13(9):814. doi: 10.3390/antibiotics13090814. PMID: 36978364 Free PMC article. Retracted.
-
In Vitro and Pre-Clinical Evaluation of Locally Isolated Phages, vB_Pae_SMP1 and vB_Pae_SMP5, Formulated as Hydrogels against Carbapenem-Resistant Pseudomonas aeruginosa.Viruses. 2022 Dec 11;14(12):2760. doi: 10.3390/v14122760. Viruses. 2022. PMID: 36560763 Free PMC article.
-
Identification, Characterization, and Genome Analysis of Two Novel Temperate Pseudomonas protegens Phages PseuP_222 and PseuP_224.Microorganisms. 2023 May 31;11(6):1456. doi: 10.3390/microorganisms11061456. Microorganisms. 2023. PMID: 37374958 Free PMC article.
-
Isolation of a bacteriophage targeting Pseudomonas aeruginosa and exhibits a promising in vivo efficacy.AMB Express. 2023 Jul 26;13(1):79. doi: 10.1186/s13568-023-01582-3. AMB Express. 2023. PMID: 37495819 Free PMC article.
-
Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Front Microbiol. 2018 May 4;9:775. doi: 10.3389/fmicb.2018.00775. eCollection 2018. Front Microbiol. 2018. PMID: 29780361 Free PMC article. Review.
Cited by
-
Isolation and Characterization of a Lytic Phage PaTJ Against Pseudomonas aeruginosa.Viruses. 2024 Nov 21;16(12):1816. doi: 10.3390/v16121816. Viruses. 2024. PMID: 39772127 Free PMC article.
References
-
- Teklemariam A.D., Al-Hindi R.R., Alharbi M.G., Alotibi I., Azhari S.A., Qadri I., Alamri T., Esmael A., Harakeh S. RETRACTED: Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics. 2023;12:497. doi: 10.3390/antibiotics12030497. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources